Back
Aligos Therapeutics Stock Price Chart
Sponsored
ALGS
Sponsored
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Sell
29
ALGS
Aligos Therapeutics
Last Price:
7.35
Seasonality Move:
-9.98%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing slight buying pressure.
Aligos Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.32 | Buy |
20-day SMA: | 7.73 | Sell |
50-day SMA: | 10.87 | Sell |
200-day SMA: | 15.84 | Sell |
8-day EMA: | 7.37 | Sell |
20-day EMA: | 8.14 | Sell |
50-day EMA: | 10 | Sell |
200-day EMA: | 15.09 | Sell |
Aligos Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 37.86 | Sell |
Chaikin Money Flow: | 3510 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.75 - 9.59) | Sell |
Bollinger Bands (100): | (9.07 - 14.19) | Sell |
Aligos Therapeutics Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 17 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 7.34 while ALGS 8-day simple moving average is 7.32, which is a Buy signal.
- The stock price of ALGS is 7.34 while Aligos Therapeutics 20-day SMA is 7.73, which makes it a Sell.
- Aligos Therapeutics 50-day simple moving average is 10.87 while ALGS share price is 7.34, making it a Sell technically.
- ALGS stock price is 7.34 and Aligos Therapeutics 200-day simple moving average is 15.84, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Sell
The current Aligos Therapeutics [ALGS] share price is $7.34. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
23.46M
Price in USD:
7.34
Share Volume:
44.63K
Aligos Therapeutics 52-Week Range
52-Week High:
30.00
52-Week Low:
6.76
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?
The Aligos Therapeutics stock price is 7.34 USD today. -
Will ALGS stock go up or go down?
Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aligos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 7.34 while ALGS 8-day exponential moving average is 7.37, which is a Sell signal.
- The stock price of ALGS is 7.34 while Aligos Therapeutics 20-day EMA is 8.14, which makes it a Sell.
- Aligos Therapeutics 50-day exponential moving average is 10.00 while ALGS share price is 7.34, making it a Sell technically.
- ALGS stock price is 7.34 and Aligos Therapeutics 200-day simple moving average is 15.09, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $37.90 per share, and a decrease next year of $10.24 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
- ALGS Moving Average Covergence Divergence (MACD) indicator is -1.04, suggesting Aligos Therapeutics is a Sell
- Aligos Therapeutics Relative Strength Index (RSI) is 37.86, which suggest Aligos Therapeutics is oversold
- The Bollinger Bands (25) for Aligos Therapeutics is (6.75 - 9.59), which suggest Aligos Therapeutics is a Sell
- The Bollinger Bands (100) for Aligos Therapeutics is (9.07 - 14.19), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.